Tech Company Financing Transactions
High Throughput Genomics Funding Round
High Throughput Genomics closed a $3.4 million Series B venture capital round on 5/4/2005. Investors included Emerging Technology Partners, Solstice Capital and Valley Ventures.
Transaction Overview
Company Name
Announced On
5/4/2005
Transaction Type
Venture Equity
Amount
$3,400,000
Round
Series B
Investors
Proceeds Purpose
HTG will use the funds to further expand manufacturing, sales, and marketing activities; hire additional personnel; and increase product trials in support of its patented ArrayPlate qNPA technology.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3430 East Global Loop
Tucson, AZ 85706
USA
Tucson, AZ 85706
USA
Phone
Website
Email Address
Overview
Headquartered in Tucson, Arizona, HTG Molecular Diagnostics' mission is to empower precision medicine at the local level.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Tim Johnson
Chief Executive Officer
John Lubniewski
Chief Financial Officer
Shaun McMeans
VP - Bus. Development
Byron Lawson
VP - Regulatory Affairs
Sam Rua
Browse more venture capital transactions:
Prev: 5/4/2005: Bayhill Therapeutics venture capital transaction
Next: 5/4/2005: Worksoft venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document funding rounds that are announced publicly. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs